These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 829388)

  • 1. [C-peptide determination as a parameter for oral diabetes therapy].
    Beischer W; Raptis S; Keller L; Kerner W; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():791-4. PubMed ID: 829388
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 3. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum C-peptide level in metabolically healthy probands, diabetics and patients with island cell tumors].
    Krause U; Cordes U; Beyer J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():794-5. PubMed ID: 196433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetes and the driving license. Studies of insulin and C-peptide levels].
    Agardh CD; Ahrén B; Bitzén PO; Scherstén B
    Lakartidningen; 1981 Jan; 78(4):236-40. PubMed ID: 7010031
    [No Abstract]   [Full Text] [Related]  

  • 7. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
    Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
    Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hemoglobin A1c and insulin C-peptide in anomalies of carbohydrate metabolism.
    Perier C; Hivert M; Frey J; Rousset H; Janin J
    Biomedicine; 1980 Nov; 33(7):232-6. PubMed ID: 7013838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma insulin and C-peptide responses to oral glucose in newly diagnosed diabetics in north-western Tanzania.
    Ahren B; Corrigan CB; Alberti KG
    East Afr Med J; 1988 Dec; 65(12):847-51. PubMed ID: 3069450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of C-peptide in the choice of treatment for diabetics].
    Laakso M; Uusitupa M; Aro A
    Duodecim; 1983; 99(7):477-85. PubMed ID: 6347652
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum C-peptide after 6 months on glibenclamide remains higher than during insulin treatment.
    Peacock I; Watts R; Selby C; Tattersall RB
    Diabetes Res; 1987 Oct; 6(2):57-9. PubMed ID: 3123115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-peptide from proinsulin e--theory and practice].
    Malmquist J; Lindgärde F; Almér LO; Johansson E
    Lakartidningen; 1982 Jul; 79(30-31):2716-9. PubMed ID: 6755106
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined glyburide and insulin therapy in type II diabetes.
    Reich A; Abraira C; Lawrence AM
    Diabetes Res; 1987 Oct; 6(2):99-104. PubMed ID: 3123116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of plasma C-peptide evaluation during the oral glucose tolerance test in infantile and juvenile obesity].
    Marincola G; Cogliati F; Mauri R; Atterrato A; Resentini M
    Minerva Pediatr; 1983 Jan; 35(1-2):77. PubMed ID: 6835186
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin therapy in relation to circulating C-peptide levels.
    Beischer W; Kerner W; Raptis S; Keller L; Beischer B; Pfeiffer EF
    Diabetes; 1978; 27 Suppl 1():235-40. PubMed ID: 415925
    [No Abstract]   [Full Text] [Related]  

  • 20. Human C-peptide in normal subjects and diabetics.
    Lu ZL; Pan XR; Sun YZ; Niu ZP; Huang PL; Chi ZS
    Chin Med J (Engl); 1981 Aug; 94(8):513-7. PubMed ID: 6791893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.